Literature DB >> 8174256

Purification of human procollagen type I carboxyl-terminal propeptide cleaved as in vivo from procollagen and used to calibrate a radioimmunoassay of the propeptide.

B J Pedersen1, M Bonde.   

Abstract

We purified human procollagen type I carboxyl-terminal propeptide (PICP) that had been cleaved as in vivo from procollagen. PICP in serum-free medium from cultured human fetal fibroblasts was purified by thiophilic adsorption chromatography, low-pressure gel filtration, and HPLC gel filtration. The purity and homogeneity of the protein was verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Amino-terminal amino acid sequencing showed that the sequences of the alpha 1 and alpha 2 chains of this PICP were identical to those of the PICP produced in vivo. The monocomponent PICP thus purified was used as calibrator in a simple equilibrium-type RIA of PICP with polyclonal antibodies raised in rabbits. The measuring range is 0.15-3.75 nmol/L, and the assay detection limit is 0.03 nmol/L. The within-run and total CVs are 2% and 4%, respectively. The reference interval for the plasma concentration of PICP in healthy women of ages > 30 years is 0.36-1.44 nmol/L (geometric mean 0.72 nmol/L, n = 154).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174256

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Circadian rhythm in type I collagen formation in postmenopausal women with and without osteopenia.

Authors:  B J Pedersen; A Schlemmer; C Rosenquist; C Hassager; C Christiansen
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

2.  Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.

Authors:  N H Birkebaek; G Esberg; K Andersen; O Wolthers; C Hassager
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

3.  Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure.

Authors:  Fang-Fang Wang; Bao-Xia Chen; Hai-Yi Yu; Lin Mi; Zi-Jian Li; Wei Gao
Journal:  J Geriatr Cardiol       Date:  2016-01       Impact factor: 3.327

4.  Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification.

Authors:  Woo-Young Seo; Jeong-Ho Kim; Du-San Baek; Su-Jung Kim; Sujin Kang; Won Suk Yang; Ji-Ae Song; Moo-Seung Lee; Sunghoon Kim; Yong-Sung Kim
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.